REGENERON PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

20 8月 2024 09:47:18 条件 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

19 8月 2024 09:50:04 条件 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

16 8月 2024 11:58:01 条件 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

15 8月 2024 09:45:08 条件 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

14 8月 2024 10:27:20 条件 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

13 8月 2024 09:50:04 条件 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

09 8月 2024 09:48:01 条件 NetDania Notify

Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast

07 8月 2024 16:05:01 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

02 8月 2024 09:46:30 条件 NetDania Notify

Regeneron Reports Second Quarter 2024 Financial and Operating Results

01 8月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation

31 7月 2024 07:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

12 7月 2024 09:45:06 条件 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

11 7月 2024 10:10:53 条件 NetDania Notify

Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD

03 7月 2024 01:00:00 条件 Nasdaq GlobeNewswire

Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

28 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

27 6月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine

26 6月 2024 17:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

25 6月 2024 09:45:03 条件 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

24 6月 2024 09:56:19 条件 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

21 6月 2024 10:29:52 条件 NetDania Notify